Effects of Curcumin Supplementation on Inflammatory Biomarkers in Adults with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Nutrients · 16.09.2026 · 18 (18) · 3028
DOI: 10.3390/nu18183028 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Nutrients, online erschienen am 16.09.2026. Verfasst von Claudio Ignacio Pérez und 2 weiteren Autor:innen. Beteiligte Einrichtung: Escuela de Nutrición y Dietética, Facultad de Medicina, Universidad Andres Bello, Santiago 8370321, Chile. Hauptthemen laut MEDLINE: Curcumin, Diabetes Mellitus, Type 2, Dietary Supplements, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background/Objectives: Chronic low-grade inflammation contributes to the pathophysiology of type 2 diabetes mellitus (T2DM). This systematic review and meta-analysis evaluated randomized evidence on the effects of oral curcumin or curcuminoid supplementation on circulating inflammatory biomarkers in adults with T2DM.
Methods
PubMed, Scopus, and Web of Science were searched from database inception through 31 August 2026. Random-effects models using restricted maximum likelihood (REML) and Hartung–Knapp confidence intervals were applied to the primary syntheses because relatively few studies contributed to each outcome.
Results
Six randomized controlled trials (RCTs; n = 472) provided compatible hs-CRP endpoint data. Curcumin supplementation was associated with lower hs-CRP concentrations (MD = −1.06 mg/L; 95% CI −1.97 to −0.16; p = 0.030; I2 = 17.3%), although sensitivity analyses involving unit-ambiguous or statistically reconstructed data increased uncertainty. Five RCTs (n = 475) contributed quantitative TNF-α data; the pooled standardized effect favored curcumin (Hedges’ g = −1.20; 95% CI −1.98 to −0.42; p = 0.013), with substantial heterogeneity (I2 = 84.9%). Evidence for IL-6 from three randomized cohorts was directionally favorable but heterogeneous and was synthesized narratively, whereas IL-1β findings were limited to a single randomized cohort.
Conclusions
Curcumin or curcuminoid supplementation may reduce hs-CRP and TNF-α in adults with T2DM; however, the strength of inference is limited by the small evidence base, heterogeneity, and inconsistencies in outcome reporting. Larger, methodologically standardized trials are warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Escuela de Nutrición y Dietética, Facultad de Medicina, Universidad Andres Bello, Santiago 8370321, Chile.
- Instituto de Ciencias Biomédicas, Facultad de Ciencias de la Salud, Universidad Autónoma de Chile, Santiago 8910060, Chile.
ORCID-Profile: Jorge Enrique González-Casanova, Diana Marcela Rojas-Gómez
Zitieren
APA
Pérez, C. I., González-Casanova, J. E., & Rojas-Gómez, D. M. (2026). Effects of Curcumin Supplementation on Inflammatory Biomarkers in Adults with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients, 18(18), 3028. https://doi.org/10.3390/nu18183028
Vancouver
Pérez CI, González-Casanova JE, Rojas-Gómez DM. Effects of Curcumin Supplementation on Inflammatory Biomarkers in Adults with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2026;18(18):3028. doi:10.3390/nu18183028
BibTeX
@article{Prez2026,
author = {Pérez, Claudio Ignacio and González-Casanova, Jorge Enrique and Rojas-Gómez, Diana Marcela},
title = {Effects of Curcumin Supplementation on Inflammatory Biomarkers in Adults with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {18},
pages = {3028},
doi = {10.3390/nu18183028}
}
EUVIMED